Industry Research Reports

Home > Reports > Service & Software > Global Metastatic Melanoma Diagnostic Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Metastatic Melanoma Diagnostic Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-02-20

Pages: 80 Pages

Report ld: 4024521

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Metastatic Melanoma Diagnostic Market Size(US$)

CAGR 2025-2031

7.9%

Market Size,2031

USD 1,389

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 880 million

Market Forecast in 2031(Value)

US$ 1,389 million

CAGR

7.9%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Metastatic Melanoma Diagnostic market size was US$ 822 million in 2024 and is forecast to a readjusted size of US$ 1389 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.

Melanoma is one of the serious types of skin cancers that develops from pigment-containing cells called as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Moles, brown spots and growths on the skin are found to be the symptoms associated with the disease. When it spreads to other places in body, it"s called metastatic, or advanced. Although in many cases metastatic melanoma can’t be cured, treatments and support can help people live longer and better. Doctors have therapies that have greatly increased survival rates. And researchers are working to find new medications that can do even more.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Metastatic Melanoma Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Melanoma Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

Myriad Genetics
Abbott Laboratories
Foundation Medicine
Pathway Genomics Corporation
Cancer Genetics
Castle Biosciences
NeoGenomics
Dermtech
Sysmex Inostics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

BRAF Mutation
Circulating Tumor Cells (CTCs)
Immunohistochemistry
Others

Segment by Application

Pathology Laboratories
Hospitals
Cancer Research Centres
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Metastatic Melanoma Diagnostic in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of Metastatic Melanoma Diagnostic manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metastatic Melanoma Diagnostic revenue, gross margin, and recent development, etc.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 BRAF Mutation

1.2.3 Circulating Tumor Cells (CTCs)

1.2.4 Immunohistochemistry

1.2.5 Others

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Pathology Laboratories

1.3.3 Hospitals

1.3.4 Cancer Research Centres

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Metastatic Melanoma Diagnostic Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Metastatic Melanoma Diagnostic Revenue Market Share by Region (2020-2025)

2.4 Global Metastatic Melanoma Diagnostic Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Metastatic Melanoma Diagnostic Market Size and Prospective (2020-2031)

2.5.2 Europe Metastatic Melanoma Diagnostic Market Size and Prospective (2020-2031)

2.5.3 Asia-Pacific Metastatic Melanoma Diagnostic Market Size and Prospective (2020-2031)

2.5.4 Latin America Metastatic Melanoma Diagnostic Market Size and Prospective (2020-2031)

2.5.5 Middle East & Africa Metastatic Melanoma Diagnostic Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Metastatic Melanoma Diagnostic Historic Market Size by Type (2020-2025)

3.2 Global Metastatic Melanoma Diagnostic Forecasted Market Size by Type (2026-2031)

3.3 Different Types Metastatic Melanoma Diagnostic Representative Players

4 Breakdown Data by Application

4.1 Global Metastatic Melanoma Diagnostic Historic Market Size by Application (2020-2025)

4.2 Global Metastatic Melanoma Diagnostic Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Metastatic Melanoma Diagnostic Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Metastatic Melanoma Diagnostic Players by Revenue (2020-2025)

5.1.2 Global Metastatic Melanoma Diagnostic Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Metastatic Melanoma Diagnostic Revenue

5.4 Global Metastatic Melanoma Diagnostic Market Concentration Analysis

5.4.1 Global Metastatic Melanoma Diagnostic Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Metastatic Melanoma Diagnostic Revenue in 2024

5.5 Global Key Players of Metastatic Melanoma Diagnostic Head office and Area Served

5.6 Global Key Players of Metastatic Melanoma Diagnostic, Product and Application

5.7 Global Key Players of Metastatic Melanoma Diagnostic, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Metastatic Melanoma Diagnostic Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Metastatic Melanoma Diagnostic Market Size by Type (2020-2025)

6.1.2.2 North America Metastatic Melanoma Diagnostic Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Metastatic Melanoma Diagnostic Market Size by Application (2020-2025)

6.1.3.2 North America Metastatic Melanoma Diagnostic Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Metastatic Melanoma Diagnostic Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Metastatic Melanoma Diagnostic Market Size by Type (2020-2025)

6.2.2.2 Europe Metastatic Melanoma Diagnostic Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Metastatic Melanoma Diagnostic Market Size by Application (2020-2025)

6.2.3.2 Europe Metastatic Melanoma Diagnostic Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 Asia-Pacific Market: Players, Segments and Downstream

6.3.1 Asia-Pacific Metastatic Melanoma Diagnostic Revenue by Company (2020-2025)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific Metastatic Melanoma Diagnostic Market Size by Type (2020-2025)

6.3.2.2 Asia-Pacific Metastatic Melanoma Diagnostic Market Share by Type (2020-2025)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific Metastatic Melanoma Diagnostic Market Size by Application (2020-2025)

6.3.3.2 Asia-Pacific Metastatic Melanoma Diagnostic Market Share by Application (2020-2025)

6.3.4 Asia-Pacific Market Trend and Opportunities

6.4 Latin America Market: Players, Segments and Downstream

6.4.1 Latin America Metastatic Melanoma Diagnostic Revenue by Company (2020-2025)

6.4.2 Latin America Market Size by Type

6.4.2.1 Latin America Metastatic Melanoma Diagnostic Market Size by Type (2020-2025)

6.4.2.2 Latin America Metastatic Melanoma Diagnostic Market Share by Type (2020-2025)

6.4.3 Latin America Market Size by Application

6.4.3.1 Latin America Metastatic Melanoma Diagnostic Market Size by Application (2020-2025)

6.4.3.2 Latin America Metastatic Melanoma Diagnostic Market Share by Application (2020-2025)

6.4.4 Latin America Market Trend and Opportunities

6.5 Middle East & Africa Market: Players, Segments and Downstream

6.5.1 Middle East & Africa Metastatic Melanoma Diagnostic Revenue by Company (2020-2025)

6.5.2 Middle East & Africa Market Size by Type

6.5.2.1 Middle East & Africa Metastatic Melanoma Diagnostic Market Size by Type (2020-2025)

6.5.2.2 Middle East & Africa Metastatic Melanoma Diagnostic Market Share by Type (2020-2025)

6.5.3 Middle East & Africa Market Size by Application

6.5.3.1 Middle East & Africa Metastatic Melanoma Diagnostic Market Size by Application (2020-2025)

6.5.3.2 Middle East & Africa Metastatic Melanoma Diagnostic Market Share by Application (2020-2025)

6.5.4 Middle East & Africa Market Trend and Opportunities

7 Key Players Profiles

7.1 Myriad Genetics

7.1.1 Myriad Genetics Company Details

7.1.2 Myriad Genetics Business Overview

7.1.3 Myriad Genetics Metastatic Melanoma Diagnostic Introduction

7.1.4 Myriad Genetics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

7.1.5 Myriad Genetics Recent Development

7.2 Abbott Laboratories

7.2.1 Abbott Laboratories Company Details

7.2.2 Abbott Laboratories Business Overview

7.2.3 Abbott Laboratories Metastatic Melanoma Diagnostic Introduction

7.2.4 Abbott Laboratories Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

7.2.5 Abbott Laboratories Recent Development

7.3 Foundation Medicine

7.3.1 Foundation Medicine Company Details

7.3.2 Foundation Medicine Business Overview

7.3.3 Foundation Medicine Metastatic Melanoma Diagnostic Introduction

7.3.4 Foundation Medicine Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

7.3.5 Foundation Medicine Recent Development

7.4 Pathway Genomics Corporation

7.4.1 Pathway Genomics Corporation Company Details

7.4.2 Pathway Genomics Corporation Business Overview

7.4.3 Pathway Genomics Corporation Metastatic Melanoma Diagnostic Introduction

7.4.4 Pathway Genomics Corporation Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

7.4.5 Pathway Genomics Corporation Recent Development

7.5 Cancer Genetics

7.5.1 Cancer Genetics Company Details

7.5.2 Cancer Genetics Business Overview

7.5.3 Cancer Genetics Metastatic Melanoma Diagnostic Introduction

7.5.4 Cancer Genetics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

7.5.5 Cancer Genetics Recent Development

7.6 Castle Biosciences

7.6.1 Castle Biosciences Company Details

7.6.2 Castle Biosciences Business Overview

7.6.3 Castle Biosciences Metastatic Melanoma Diagnostic Introduction

7.6.4 Castle Biosciences Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

7.6.5 Castle Biosciences Recent Development

7.7 NeoGenomics

7.7.1 NeoGenomics Company Details

7.7.2 NeoGenomics Business Overview

7.7.3 NeoGenomics Metastatic Melanoma Diagnostic Introduction

7.7.4 NeoGenomics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

7.7.5 NeoGenomics Recent Development

7.8 Dermtech

7.8.1 Dermtech Company Details

7.8.2 Dermtech Business Overview

7.8.3 Dermtech Metastatic Melanoma Diagnostic Introduction

7.8.4 Dermtech Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

7.8.5 Dermtech Recent Development

7.9 Sysmex Inostics

7.9.1 Sysmex Inostics Company Details

7.9.2 Sysmex Inostics Business Overview

7.9.3 Sysmex Inostics Metastatic Melanoma Diagnostic Introduction

7.9.4 Sysmex Inostics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

7.9.5 Sysmex Inostics Recent Development

8 Metastatic Melanoma Diagnostic Market Dynamics

8.1 Metastatic Melanoma Diagnostic Industry Trends

8.2 Metastatic Melanoma Diagnostic Market Drivers

8.3 Metastatic Melanoma Diagnostic Market Challenges

8.4 Metastatic Melanoma Diagnostic Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Metastatic Melanoma Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Metastatic Melanoma Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Metastatic Melanoma Diagnostic Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Metastatic Melanoma Diagnostic Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Metastatic Melanoma Diagnostic Revenue Share by Region (2020-2025)

Table 6. Global Metastatic Melanoma Diagnostic Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Metastatic Melanoma Diagnostic Revenue Share Forecast by Region (2026-2031)

Table 8. Global Metastatic Melanoma Diagnostic Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Metastatic Melanoma Diagnostic Revenue Market Share by Type (2020-2025)

Table 10. Global Metastatic Melanoma Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Metastatic Melanoma Diagnostic Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Metastatic Melanoma Diagnostic Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Metastatic Melanoma Diagnostic Revenue Market Share by Application (2020-2025)

Table 15. Global Metastatic Melanoma Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Metastatic Melanoma Diagnostic Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Metastatic Melanoma Diagnostic Application

Table 18. Global Metastatic Melanoma Diagnostic Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Metastatic Melanoma Diagnostic Market Share by Players (2020-2025)

Table 20. Global Top Metastatic Melanoma Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Melanoma Diagnostic as of 2024)

Table 21. Ranking of Global Top Metastatic Melanoma Diagnostic Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Metastatic Melanoma Diagnostic Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Metastatic Melanoma Diagnostic, Headquarters and Area Served

Table 24. Global Key Players of Metastatic Melanoma Diagnostic, Product and Application

Table 25. Global Key Players of Metastatic Melanoma Diagnostic, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Metastatic Melanoma Diagnostic Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Metastatic Melanoma Diagnostic Revenue Market Share by Company (2020-2025)

Table 29. North America Metastatic Melanoma Diagnostic Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Metastatic Melanoma Diagnostic Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Metastatic Melanoma Diagnostic Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Metastatic Melanoma Diagnostic Revenue Market Share by Company (2020-2025)

Table 33. Europe Metastatic Melanoma Diagnostic Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Metastatic Melanoma Diagnostic Market Size by Application (2020-2025) & (US$ Million)

Table 35. Asia-Pacific Metastatic Melanoma Diagnostic Revenue by Company (2020-2025) & (US$ Million)

Table 36. Asia-Pacific Metastatic Melanoma Diagnostic Revenue Market Share by Company (2020-2025)

Table 37. Asia-Pacific Metastatic Melanoma Diagnostic Market Size by Type (2020-2025) & (US$ Million)

Table 38. Asia-Pacific Metastatic Melanoma Diagnostic Market Size by Application (2020-2025) & (US$ Million)

Table 39. Latin America Metastatic Melanoma Diagnostic Revenue by Company (2020-2025) & (US$ Million)

Table 40. Latin America Metastatic Melanoma Diagnostic Revenue Market Share by Company (2020-2025)

Table 41. Latin America Metastatic Melanoma Diagnostic Market Size by Type (2020-2025) & (US$ Million)

Table 42. Latin America Metastatic Melanoma Diagnostic Market Size by Application (2020-2025) & (US$ Million)

Table 43. Middle East & Africa Metastatic Melanoma Diagnostic Revenue by Company (2020-2025) & (US$ Million)

Table 44. Middle East & Africa Metastatic Melanoma Diagnostic Revenue Market Share by Company (2020-2025)

Table 45. Middle East & Africa Metastatic Melanoma Diagnostic Market Size by Type (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Metastatic Melanoma Diagnostic Market Size by Application (2020-2025) & (US$ Million)

Table 47. Myriad Genetics Company Details

Table 48. Myriad Genetics Business Overview

Table 49. Myriad Genetics Metastatic Melanoma Diagnostic Product

Table 50. Myriad Genetics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 51. Myriad Genetics Recent Development

Table 52. Abbott Laboratories Company Details

Table 53. Abbott Laboratories Business Overview

Table 54. Abbott Laboratories Metastatic Melanoma Diagnostic Product

Table 55. Abbott Laboratories Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 56. Abbott Laboratories Recent Development

Table 57. Foundation Medicine Company Details

Table 58. Foundation Medicine Business Overview

Table 59. Foundation Medicine Metastatic Melanoma Diagnostic Product

Table 60. Foundation Medicine Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 61. Foundation Medicine Recent Development

Table 62. Pathway Genomics Corporation Company Details

Table 63. Pathway Genomics Corporation Business Overview

Table 64. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Product

Table 65. Pathway Genomics Corporation Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 66. Pathway Genomics Corporation Recent Development

Table 67. Cancer Genetics Company Details

Table 68. Cancer Genetics Business Overview

Table 69. Cancer Genetics Metastatic Melanoma Diagnostic Product

Table 70. Cancer Genetics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 71. Cancer Genetics Recent Development

Table 72. Castle Biosciences Company Details

Table 73. Castle Biosciences Business Overview

Table 74. Castle Biosciences Metastatic Melanoma Diagnostic Product

Table 75. Castle Biosciences Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 76. Castle Biosciences Recent Development

Table 77. NeoGenomics Company Details

Table 78. NeoGenomics Business Overview

Table 79. NeoGenomics Metastatic Melanoma Diagnostic Product

Table 80. NeoGenomics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 81. NeoGenomics Recent Development

Table 82. Dermtech Company Details

Table 83. Dermtech Business Overview

Table 84. Dermtech Metastatic Melanoma Diagnostic Product

Table 85. Dermtech Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 86. Dermtech Recent Development

Table 87. Sysmex Inostics Company Details

Table 88. Sysmex Inostics Business Overview

Table 89. Sysmex Inostics Metastatic Melanoma Diagnostic Product

Table 90. Sysmex Inostics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 91. Sysmex Inostics Recent Development

Table 92. Metastatic Melanoma Diagnostic Market Trends

Table 93. Metastatic Melanoma Diagnostic Market Drivers

Table 94. Metastatic Melanoma Diagnostic Market Challenges

Table 95. Metastatic Melanoma Diagnostic Market Restraints

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Metastatic Melanoma Diagnostic Product Picture

Figure 2. Global Metastatic Melanoma Diagnostic Market Share by Type: 2024 VS 2031

Figure 3. BRAF Mutation Features

Figure 4. Circulating Tumor Cells (CTCs) Features

Figure 5. Immunohistochemistry Features

Figure 6. Others Features

Figure 7. Global Metastatic Melanoma Diagnostic Market Share by Application: 2024 VS 2031

Figure 8. Pathology Laboratories

Figure 9. Hospitals

Figure 10. Cancer Research Centres

Figure 11. Others

Figure 12. Metastatic Melanoma Diagnostic Report Years Considered

Figure 13. Global Metastatic Melanoma Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Metastatic Melanoma Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Metastatic Melanoma Diagnostic Revenue Market Share by Region: 2020 VS 2024

Figure 16. North America Metastatic Melanoma Diagnostic Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Europe Metastatic Melanoma Diagnostic Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Asia-Pacific Metastatic Melanoma Diagnostic Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Latin America Metastatic Melanoma Diagnostic Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Middle East & Africa Metastatic Melanoma Diagnostic Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Global Metastatic Melanoma Diagnostic Market Share by Players in 2024

Figure 22. Global Top Metastatic Melanoma Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Melanoma Diagnostic as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Metastatic Melanoma Diagnostic Revenue in 2024

Figure 24. North America Metastatic Melanoma Diagnostic Market Share by Type (2020-2025)

Figure 25. North America Metastatic Melanoma Diagnostic Market Share by Application (2020-2025)

Figure 26. Europe Metastatic Melanoma Diagnostic Market Share by Type (2020-2025)

Figure 27. Europe Metastatic Melanoma Diagnostic Market Share by Application (2020-2025)

Figure 28. Asia-Pacific Metastatic Melanoma Diagnostic Market Share by Type (2020-2025)

Figure 29. Asia-Pacific Metastatic Melanoma Diagnostic Market Share by Application (2020-2025)

Figure 30. Latin America Metastatic Melanoma Diagnostic Market Share by Type (2020-2025)

Figure 31. Latin America Metastatic Melanoma Diagnostic Market Share by Application (2020-2025)

Figure 32. Middle East & Africa Metastatic Melanoma Diagnostic Market Share by Type (2020-2025)

Figure 33. Middle East & Africa Metastatic Melanoma Diagnostic Market Share by Application (2020-2025)

Figure 34. Myriad Genetics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 35. Abbott Laboratories Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 36. Foundation Medicine Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 37. Pathway Genomics Corporation Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 38. Cancer Genetics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 39. Castle Biosciences Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 40. NeoGenomics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 41. Dermtech Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 42. Sysmex Inostics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 43. Bottom-up and Top-down Approaches for This Report

Figure 44. Data Triangulation

Figure 45. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Metastatic Melanoma Diagnostic in 2031? zhanKai

The global market size of Metastatic Melanoma Diagnostic in 2031 was 1389 Million USD.

What is the annual compound growth rate of the global Metastatic Melanoma Diagnostic market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Metastatic Melanoma Diagnostic in 2025? shouQi

Which companies rank high in the global Metastatic Melanoma Diagnostic market? shouQi

Related Reports

Metastatic Melanoma Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Metastatic Melanoma Diagnostic was estimated to be worth US$ 880 million in 2025 and is projected to reach US$ 1487 million, growing at a CAGR of 7.9% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 109
USD 3950.00
(Single User License)
Global Metastatic Melanoma Diagnostic Market Research Report 2026
The global Metastatic Melanoma Diagnostic market was valued at US$ 880 million in 2025 and is anticipated to reach US$ 1487 million by 2032, at a CAGR of 7.9% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 106
USD 2900.00
(Single User License)
Global Metastatic Melanoma Diagnostic Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Metastatic Melanoma Diagnostic market is projected to grow from US$ 822 million in 2024 to US$ 1389 million by 2031, at a CAGR of 7.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 123
USD 4900.00
(Single User License)
Metastatic Melanoma Diagnostic- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Metastatic Melanoma Diagnostic was estimated to be worth US$ 822 million in 2024 and is forecast to a readjusted size of US$ 1389 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 90
USD 3950.00
(Single User License)
Global Metastatic Melanoma Diagnostic Market Research Report 2025
The global market for Metastatic Melanoma Diagnostic was valued at US$ 822 million in the year 2024 and is projected to reach a revised size of US$ 1389 million by 2031, growing at a CAGR of 7.9% during the forecast period.
Published Date: 2025-02-20
Pages: 78
USD 2900.00
(Single User License)
Global Metastatic Melanoma Diagnostic Market Insights, Forecast to 2030
Melanoma is one of the serious types of skin cancers that develops from pigment-containing cells called as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Moles, brown spots and growths on the skin are found to be the symptoms associated with the disease. When it spreads to other places in body, it's called metastatic, or advanced. Although in many cases metastatic melanoma can’t be cured, treatments and support can help people live longer and better. Doctors have therapies that have greatly increased survival rates. And researchers are working to find new medications that can do even more.
Published Date: 2024-04-15
Pages: 85
USD 4900.00
(Single User License)
Metastatic Melanoma Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Melanoma is one of the serious types of skin cancers that develops from pigment-containing cells called as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Moles, brown spots and growths on the skin are found to be the symptoms associated with the disease. When it spreads to other places in body, it's called metastatic, or advanced. Although in many cases metastatic melanoma can’t be cured, treatments and support can help people live longer and better. Doctors have therapies that have greatly increased survival rates. And researchers are working to find new medications that can do even more.
Published Date: 2024-02-23
Pages: 93
USD 3950.00
(Single User License)
Global Metastatic Melanoma Diagnostic Market Research Report 2024
Melanoma is one of the serious types of skin cancers that develops from pigment-containing cells called as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Moles, brown spots and growths on the skin are found to be the symptoms associated with the disease. When it spreads to other places in body, it's called metastatic, or advanced. Although in many cases metastatic melanoma can’t be cured, treatments and support can help people live longer and better. Doctors have therapies that have greatly increased survival rates. And researchers are working to find new medications that can do even more.
Published Date: 2024-01-17
Pages: 77
USD 2900.00
(Single User License)

Metastatic Melanoma Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Metastatic Melanoma Diagnostic was estimated to be worth US$ 880 million in 2025 and is projected to reach US$ 1487 million, growing at a CAGR of 7.9% from 2026 to 2032.
Published: 2026-07-14
Pages: 109
USD 3950.00 (Single User License)
Global Metastatic Melanoma Diagnostic Market Research Report 2026
The global Metastatic Melanoma Diagnostic market was valued at US$ 880 million in 2025 and is anticipated to reach US$ 1487 million by 2032, at a CAGR of 7.9% from 2026 to 2032.
Published: 2026-04-21
Pages: 106
USD 2900.00 (Single User License)
Global Metastatic Melanoma Diagnostic Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Metastatic Melanoma Diagnostic market is projected to grow from US$ 822 million in 2024 to US$ 1389 million by 2031, at a CAGR of 7.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 123
USD 4900.00 (Single User License)
Metastatic Melanoma Diagnostic- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Metastatic Melanoma Diagnostic was estimated to be worth US$ 822 million in 2024 and is forecast to a readjusted size of US$ 1389 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 90
USD 3950.00 (Single User License)
Global Metastatic Melanoma Diagnostic Market Research Report 2025
The global market for Metastatic Melanoma Diagnostic was valued at US$ 822 million in the year 2024 and is projected to reach a revised size of US$ 1389 million by 2031, growing at a CAGR of 7.9% during the forecast period.
Published: 2025-02-20
Pages: 78
USD 2900.00 (Single User License)
Global Metastatic Melanoma Diagnostic Market Insights, Forecast to 2030
Melanoma is one of the serious types of skin cancers that develops from pigment-containing cells called as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Moles, brown spots and growths on the skin are found to be the symptoms associated with the disease. When it spreads to other places in body, it's called metastatic, or advanced. Although in many cases metastatic melanoma can’t be cured, treatments and support can help people live longer and better. Doctors have therapies that have greatly increased survival rates. And researchers are working to find new medications that can do even more.
Published: 2024-04-15
Pages: 85
USD 4900.00 (Single User License)
Metastatic Melanoma Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Melanoma is one of the serious types of skin cancers that develops from pigment-containing cells called as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Moles, brown spots and growths on the skin are found to be the symptoms associated with the disease. When it spreads to other places in body, it's called metastatic, or advanced. Although in many cases metastatic melanoma can’t be cured, treatments and support can help people live longer and better. Doctors have therapies that have greatly increased survival rates. And researchers are working to find new medications that can do even more.
Published: 2024-02-23
Pages: 93
USD 3950.00 (Single User License)
Global Metastatic Melanoma Diagnostic Market Research Report 2024
Melanoma is one of the serious types of skin cancers that develops from pigment-containing cells called as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Moles, brown spots and growths on the skin are found to be the symptoms associated with the disease. When it spreads to other places in body, it's called metastatic, or advanced. Although in many cases metastatic melanoma can’t be cured, treatments and support can help people live longer and better. Doctors have therapies that have greatly increased survival rates. And researchers are working to find new medications that can do even more.
Published: 2024-01-17
Pages: 77
USD 2900.00 (Single User License)